AeroLeads people directory · profile
Chris Langmead Email & Phone Number
Chief Executive Officer and Co-Founder
at
Phrenix Therapeutics
LinkedIn matched
✓ Verified Jun 2026
3 data sources
Profile completeness 100%
Current company
Role
Chief Executive Officer and Co-Founder
Location
Parkville, Victoria, Australia
Company size
Who is Chris Langmead? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Chris Langmead is listed as Chief Executive Officer and Co-Founder at Phrenix Therapeutics, a company with 4 employees, based in Parkville, Victoria, Australia. AeroLeads shows a matched LinkedIn profile for Chris Langmead.
Chris Langmead previously worked as Professor, Neuromedicines Discovery Centre at Monash University and Professor and Director, Neuromedicines Discovery Centre at Monash University. Chris Langmead holds Phd, Molecular Pharmacology from Ucl.
Company email context
Email format at Phrenix Therapeutics
This section adds company-level context without repeating Chris Langmead's masked contact details.
Phrenix Therapeutics
Review company-level records connected to Chris Langmead before choosing the right outreach path.
Profile bio
About Chris Langmead
Leadership and management of multiple drug discovery projects from target validation / hit identification through to clinical candidate selection, primarily for G protein-coupled receptor targets.Track record of success and expertise in:-neuropsychiatry drug discovery -application of structure-based approaches to NCE discovery-analytical and mechanistic pharmacology -integration of pharmacology, medicinal chemistry, ADME/PK and in vivo models of disease
Listed skills include Drug Discovery, Pharmacology, In Vitro, Biochemistry, and 28 others.
Current workplace
Chris Langmead's current company
Company context helps verify the profile and gives searchers a useful next step.
Phrenix Therapeutics
13 roles · 16 years
Chris Langmead work experience
A career timeline built from the work history available for this profile.
Professor, Neuromedicines Discovery Centre
Professor And Director, Neuromedicines Discovery Centre
Current
Aug 2023 - Present
Head, Servier Drug Discovery Program
CurrentManagement of GPCR and neuroscience drug discovery collaboration between the Monash Institute of Pharmaceutical Sciences and Servier Laboratories
Jun 2012 - Present
Professor And Deputy Director, Neuromedicines Discovery Centre
Nov 2021 - Aug 2023
Co-Lead, Neuroscience & Mental Health Therapeutic Program Area
Jan 2020 - Jul 2022
Chief Scientific Advisor
Current
Jul 2023 - Present
Chief Executive Officer
Current
Jul 2022 - Present
Fellow
Current
Jan 2011 - Present
Head Of Pharmacology
Position as Head of Pharmacology at Heptares Therapeutics to work on GPCR targets using structure-based drug discovery approaches, with the company's unique access to x-ray crystallography data of GPCR targets and StaR technology.Responsible for in vitro and in vivo pharmacology and ADMET at all stages of drug discovery up to clincal candidate selection. I.
Feb 2009 - May 2012
2010 - 2012
~2 yrs
Team Leader, Biochemical Pharmacology
Leader of a Biochemical Pharmacology team responsible for validation of novel targets for depression & anxiety, bipolar disorder and schizophrenia. Use of compound and RNAi-based approaches in combination with in vitro pharmacological and biochemical techniques in recombinant, primary and stem cell lines and native tissue to characterise a diverse array of.
Oct 2006 - Jan 2009
Principal Scientist
Co-ordinate and perform wide range of in vitro and ex vivo pharmacological techniques to support ongoing gene to target, target to lead and lead optimisation programmes for schizophrenia and bipolar disorder.Extensive experience in the use of molecular pharmacology / biology techniques to augment the drug discovery process. Key contact for data analysis.
Oct 1998 - Oct 2006
2 education records
Chris Langmead education
Phd, Molecular Pharmacology
Ba (Hons), Natural Sciences
FAQ
Frequently asked questions about Chris Langmead
Quick answers generated from the profile data available on this page.
What company does Chris Langmead work for?
Chris Langmead works for Phrenix Therapeutics.
What is Chris Langmead's role at Phrenix Therapeutics?
Chris Langmead is listed as Chief Executive Officer and Co-Founder at Phrenix Therapeutics.
Where is Chris Langmead based?
Chris Langmead is based in Parkville, Victoria, Australia while working with Phrenix Therapeutics.
What companies has Chris Langmead worked for?
Chris Langmead has worked for Phrenix Therapeutics, Monash University, Pacalis Therapeutics Pty Ltd, British Pharmacological Society, and Sosei Heptares.
How can I contact Chris Langmead?
You can use AeroLeads to view verified contact signals for Chris Langmead at Phrenix Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Chris Langmead attend?
Chris Langmead holds Phd, Molecular Pharmacology from Ucl.
What skills is Chris Langmead known for?
Chris Langmead is listed with skills including Drug Discovery, Pharmacology, In Vitro, Biochemistry, Gpcrs, Life Sciences, Clinical Development, and Neuroscience.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialPeople with similar names
Check these profiles if this is not the Chris Langmead you were looking for.
View similar profiles
